Carfilzomib, cyclophosphamide, and dexamethasone (KCd) for the treatment of triple-class relapsed/refractory multiple myeloma (RRMM)

Dante Pennipede, Ghulam Rehman Mohyuddin, Ryan Hawkins, Siddhartha Ganguly, Leyla Shune, Nausheen Ahmed, Meera Mohan, Wei Cui, Zahra Mahmoudjafari, Joseph McGuirk, Shebli Atrash, Al Ola Abdallah

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Carfilzomib, cyclophosphamide, and dexamethasone (KCd) for the treatment of triple-class relapsed/refractory multiple myeloma (RRMM)'. Together they form a unique fingerprint.

Medicine & Life Sciences